Labcorp poster evaluates orthogonal RNA and DNA integrity checks for CGT bioanalysis
Company / institutional announcement · Labcorp
Source published: · Event / reporting date: 2026-11-03
Site published: 2026-11-06 · Updated: 2026-11-06
This source is linked automatically. Choose a question to get started.
What changed
Labcorp published a conference-poster summary on independent RNA and DNA integrity assessment in cell and gene therapy bioanalysis. It evaluates Agilent TapeStation microfluidic electrophoresis as an orthogonal quality-control tool alongside qPCR and RT-qPCR, which do not directly measure overall integrity. The public summary describes the evaluation's objective and rationale, without quantitative performance results or peer-reviewed publication metadata.
Why it may matter
Analysis: Orthogonal integrity checks may help teams distinguish sample degradation from assay variability when interpreting molecular bioanalytical data.
The interpretation above is analysis, not a conclusion attributed to the original source.
Read the original source ↗Prepared through Biotech Assistant’s automated research workflow. Editorial standards and corrections